Company wins U.S. contract for anthrax vaccine
Emergency Management Alert, January 28, 2003
Vaccine maker Avant Immunotherapeutics said January 22 it won a U.S. government contract to work on an oral vaccine to protect troops against both anthrax and plague infections, Reuters reports.
The vaccine will use the cholera bacterium as a "bus" to carry in proteins to protect against plague, anthrax, and cholera. However, it could be years before a working vaccine emerges. One of the objections to the current anthrax vaccine is that it causes soreness at the injection site, but an oral vaccine would have no such side effect.
The U.S. Department of Defense contracted the work to DynPort Vaccine Company, which in turn subcontracted to Avant, a Needham, MA-based biotechnology company specializing in vaccines.
Related Products
Most Popular
- Articles
-
- HIPAA Q&A: Answering service messages
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- Q/A: Volume requirement for reporting hydration services
- Q&A: Coding for dry skin due to cold weather
- Are your workforce members texting PHI?
- Topic: CMS, OESS post new security compliance review information, checklist
- What does case-mix index mean to you?
- OB services: Coding inside and outside of the package
- Catch up on what's new with injections and infusions
- Capturing all necessary codes for IUD insertion and removal can be challenging
- E-mailed
-
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- Q/A: Volume requirement for reporting hydration services
- HIPAA Q&A: Level of encryption needed for email
- HIPAA Q&A: Answering service messages
- Q&A: Coding for sepsis when other conditions are present
- Are your workforce members texting PHI?
- HIPAA Q&A: TPO disclosures to a business associate
- Q&A: Coding for dry skin due to cold weather
- What does case-mix index mean to you?
- 2012 CPT code changes for ASCs: Shoulder and knee scopes and pain management
- Searched
